Researcher Profile Statistics: Aboyewa, Jumoke Adebisi
Geo Map
Region
#
NA - North America
7
AF - Africa
2
AS - Asia, other
2
EU - Europe
1
SA - South America
1
Total
13
Country
#
US - United States of America
7
ZA - South Africa
2
CO - Colombia
1
GB - United Kingdom
1
IN - India
1
KR - Korea
1
Total
13
City
#
Fremont
5
Bogotá
1
Cape Town
1
Hyderabad
1
Kidlington
1
Oakland
1
Pretoria
1
San Jose
1
Seoul
1
Total
13
Most viewed items
#
ID: 2799 - The role of gold nanoparticles synthesized using extracts of cyclopia intermedia in the anticancer efficacy of doxorubicin
307
Total
307
Most type viewed
#
ID: other -
0
ID: journal -
0
ID: conference -
0
ID: patent -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
0
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2022
0 0
0 0 21 7
7 16 15 9
5 1
81
2023
5 8
7 14 11 10
5 4 6 11
8 34
123
2024
5 36
10 14 10 17
11 0 0 0
0 0
103
Ever
307
Geo Map
Region | # |
---|---|
NA - North America | 7 |
AF - Africa | 2 |
AS - Asia, other | 2 |
EU - Europe | 1 |
SA - South America | 1 |
Total | 13 |
Country | # |
---|---|
US - United States of America | 7 |
ZA - South Africa | 2 |
CO - Colombia | 1 |
GB - United Kingdom | 1 |
IN - India | 1 |
KR - Korea | 1 |
Total | 13 |
City | # |
---|---|
Fremont | 5 |
Bogotá | 1 |
Cape Town | 1 |
Hyderabad | 1 |
Kidlington | 1 |
Oakland | 1 |
Pretoria | 1 |
San Jose | 1 |
Seoul | 1 |
Total | 13 |
Most viewed items | # |
---|---|
ID: 2799 - The role of gold nanoparticles synthesized using extracts of cyclopia intermedia in the anticancer efficacy of doxorubicin | 307 |
Total | 307 |
Most type viewed | # |
---|---|
ID: other - | 0 |
ID: journal - | 0 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 0 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022 | 0 | 0 | 0 | 0 | 21 | 7 | 7 | 16 | 15 | 9 | 5 | 1 | 81 |
2023 | 5 | 8 | 7 | 14 | 11 | 10 | 5 | 4 | 6 | 11 | 8 | 34 | 123 |
2024 | 5 | 36 | 10 | 14 | 10 | 17 | 11 | 0 | 0 | 0 | 0 | 0 | 103 |
Ever | 307 |